Friday - April 24, 2026

Category Archives: Pharmaceuticals & Biotech

Major Depressive Disorder Treatment Pipeline Shows Strong Momentum as 75+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Major Depressive Disorder Pipeline Insight 2026” report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Major Depressive Disorder pipeline landscape. It covers the Major Depressive Disorder pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Sarcopenia Clinical Trial Pipeline Expands as 18+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Sarcopenia Pipeline Insight 2026” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in the Sarcopenia pipeline landscape. It covers the Sarcopenia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Sarcopenia therapeutics … Continue reading →

Dengue Clinical Trial Pipeline Shows Potential with Active Contributions from 20+ Key Companies | DelveInsight

DelveInsight’s, “Dengue Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Dengue pipeline landscape. It covers the Dengue pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Dengue therapeutics assessment … Continue reading →

Generalized Myasthenia Gravis Clinical Trial Pipeline Accelerates as 10+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Generalized Myasthenia Gravis Pipeline Insight 2026” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Generalized Myasthenia Gravis (gMG) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Sjögren’s Disease Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Sjogren’s Syndrome Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Sjogren’s Syndrome pipeline landscape. It covers the Sjogren’s Syndrome pipeline drugs profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Compounding Pharmacy Market to Reach $19.41 Billion by 2030 Driven by Drug Shortages and Personalized Medicine Demand

Compounding Pharmacy Market by Product (Oral, Topical, Parenteral), Compounding Type (Ingredient Alteration, Dosage Alteration), Therapeutic Application (Pain Management, HRT), Sterility (Sterile), End User (Pediatric, Adult) – Global forecast to 2030 According to MarketsandMarkets™, the global compounding pharmacy market is projected … Continue reading →

Antibody Therapeutics Market to Reach $479.0 Billion by 2028 Driven by Oncology Demand and Biologic Innovation

Antibody Therapeutics Market by Format (Monoclonal, Polyclonal, Antibody Fragment, Bispecific), Disease Area (Oncology, Autoimmune & Inflammatory, Neurology, Hematology, Infectious), Source (Human, Chimeric), Route (IV, SC) & Region – Global Forecast to 2028 According to MarketsandMarkets™, the global antibody therapeutics market … Continue reading →

Urinalysis Market to Reach $6.8 Billion by 2029 Driven by Rising Demand for Early Disease Detection

Urinalysis Market by Product (Consumables (Pregnancy & Fertility Kits, Dipsticks, Disposable, Reagents), Instruments (Automated, Semi-automated, PoC Analyzers)), Test Type (Biochemical, Sediment), Application (UTI, Diabetes) – Global Forecast to 2029 According to MarketsandMarkets™, the global urinalysis market is projected to grow … Continue reading →

Veterinary Dermatology Market to Reach $30.31 Billion by 2030 Amid Rising Pet Ownership and Skin Disease Prevalence

Veterinary Dermatology Market by Route of Administration, Product type (Antibacterial, Antifungal, Antiparasitic Drugs, Monoclonal Antibodies), Condition type (Parasitic Infections, Infectious Diseases, Skin Cancer), Animal type – Global Forecast to 2030 According to MarketsandMarkets™, the global veterinary dermatology market is projected … Continue reading →

SmallCap Emerge: ENVB, SMX, ANY, ELPW Across High-Growth Sectors

A diverse group of small-cap companies spanning biotechnology, artificial intelligence infrastructure, supply chain authentication, and advanced energy storage is drawing increased attention as sector-specific catalysts and macro trends continue to drive investor focus, see below: Enveric Biosciences (NASDAQ: ENVB) Expands … Continue reading →